Avelumab in metastatic collecting duct carcinoma of the kidney: a case report

BACKGROUND: Collecting duct carcinoma (CDC) of the kidney is associated with an aggressive course, limited response to treatment, and poor prognosis. Platinum-based chemotherapy is currently recommended as the first-line treatment in patients with metastatic CDC. Accumulating evidence supports the u...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyrgidis, Nikolaos, Sokolakis, Ioannis, Haltmair, Gena, Heller, Vitus, Hatzichristodoulou, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262369/
https://www.ncbi.nlm.nih.gov/pubmed/37308983
http://dx.doi.org/10.1186/s13256-023-03973-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262369/
https://www.ncbi.nlm.nih.gov/pubmed/37308983
http://dx.doi.org/10.1186/s13256-023-03973-3

Ejemplares similares